Neoplasms

Digestive System Diseases

Gland and Hormone Related Diseases

All Conditions

Rare Diseases

Pancreatic Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Endocrine Gland Neoplasms

Gastrointestinal Diseases

Pancreatic Diseases

Endocrine System Diseases

Pancreatic Cancer

Drug GC4711

Placebo

GTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following chemotherapy in patients with unresectable or borderline resectable nonmetastatic

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer

Overall survival is defined as the time from randomization to the date of death from any cause. The number of subjects that have died during this time period is the reported outcome measure.

Galera Therapeutics, Inc.

Arm A Active GC4711

Arm B Placebo

Total

Age, Categorical

Sex: Female, Male

Race (NIH/OMB)

Modified Intent to Treat Population that includes all randomized subjects that received at least one dose of GC4711/Placebo

Study was terminated early by the Sponsor based on a futility analysis that was conducted in which the trial met the prespecified early termination rules. The last randomized subject did not complete protocol therapy but was followed for safety for a period of 30 days post the last administration of GC4711/Placebo +SBRT.

Judy Schnyder, Sr. Vice President Clinical Operations and Data Management

Modified Intent to Treat Population that includes all randomized subjects that received at least one dose of GC4711/Placebo.

Overall Survival

Overall Study

Spots Global Cancer Trial Database for drug gc4711

Every month we try and update this database with for drug gc4711 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for drug gc4711

Every month we try and update this database with for drug gc4711 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for drug gc4711 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.